Ovarian Cancer News

Tests Detect Ovarian Cancer at Early Stage, But Benefits Still Uncertain (March 31, 2009)

According to early results from a large randomized study, screening for ovarian cancer using CA125 testing and/or transvaginal ultrasound may detect ovarian cancer at an earlier stage. It remains uncertain whether screening will improve survival, however,... Continue Reading

Fertility Drugs Do Not Increase Risk of Ovarian Cancer (February 12, 2009)

Fertility Drugs Do Not Increase Risk of Ovarian Cancer According to the results of a study conducted in Denmark and published in the British Medical Journal, use of fertility drugs does not increase the risk of ovarian cancer. The question of whether... Continue Reading

For Optimum Care of Gynecologic Cancers, Consult Your Gynecologic Oncologist About Medication Concerns (February 8, 2009)

As a patient or caregiver affected by a gynecologic cancer diagnosis, you can help your gynecologic oncologist ensure that you or your loved one receive the best possible care. Learn all about each prescribed medicine—both new drugs and routine drugs... Continue Reading

Genetic Testing For Women at High Risk of Ovarian Cancer (February 6, 2009)

When risk is assessed appropriately and testing is managed effectively, genetic testing for BRCA1 and BRCA2 mutations can provide patients at risk of ovarian cancer with information, options, and ultimately empowerment. By Krishnansu S. Tewari, MD, FACOG,... Continue Reading

Understanding Hereditary Breast and Ovarian Cancer (February 6, 2009)

Recent studies have explored the limitations of genetic testing for breast and ovarian cancer risk. As well, these studies have clarified cancer risk among women with and without known genetic mutations. Inherited mutations in two genes—BRCA1 and BRCA2—have... Continue Reading

Four Points to Remember About Heredity and Ovarian Cancer (February 6, 2009)

  Hereditary predisposition to ovarian cancer accounts for small (5–10%) but significant group of patients. Recognition of this fact allows women and their physicians to assess the role of genetic counseling and testing to determine their risk. If... Continue Reading

Ask the Doctor: Questions and Answers About Ovarian Cancer (February 6, 2009)

With Andrew W. Menzin, MD, FACOG, FACS Q. Is heredity an important factor in ovarian cancer? A. Only 5–10% of ovarian cancers are thought to occur due to a hereditary predisposition. Despite this fact, knowledge of family history is important information... Continue Reading

Preventive Removal of the Ovaries and Fallopian Tubes Reduces Risk of Breast, Ovarian, and Fallopian Tube Cancers Among Women with BRCA Mutations (February 4, 2009)

Preventive Removal of the Ovaries and Fallopian Tubes Reduces Risk of Breast, Ovarian, and Fallopian Tube Cancers Among Women with BRCA Mutations Risk-reducing salpingo-oophorectomy (RRSO), or the preventive removal of the ovaries and fallopian tubes,... Continue Reading

Obesity Linked with Increased Risk of Ovarian Cancer (January 7, 2009)

Obesity Linked with Increased Risk of Ovarian Cancer Among women who have never used postmenopausal hormones, those who are obese are almost twice as likely to develop ovarian cancer as those who are a healthy weight. These results were published in the... Continue Reading

The Gynecologic Oncology Group: Advancing The Prevention And The Treatment Of Gynecologic Cancers (September 16, 2008)

The Gynecologic Oncology Group: Advancing The Prevention And The Treatment Of Gynecologic Cancers The Gynecologic Oncology Group (GOG), established in 1970 by a group of gynecologic surgeons interested in promoting a “collaborative research effort,... Continue Reading